サンプル依頼リスト カート
  • English
  • Korean
  • Traditional Chinese
  • Simplified Chinese
デフォルト表紙
市場調査レポート
商品コード
1721231

フェムテックの世界市場調査レポート：産業分析、規模、シェア、成長、動向、2025年～2033年の予測

Global Femtech Market Research Report - Industry Analysis, Size, Share, Growth, Trends and Forecast 2025 to 2033

出版日
ページ情報
英文 152 Pages
納期
即日から翌営業日
カスタマイズ可能
価格
価格表記: USDを日本円(税抜)に換算
本日の銀行送金レート: 1USD=145.81円
フェムテックの世界市場調査レポート：産業分析、規模、シェア、成長、動向、2025年～2033年の予測
出版日: 2025年04月01日
発行: Value Market Research
ページ情報: 英文 152 Pages
納期: 即日から翌営業日
GIIご利用のメリット
  • 全表示
  • 概要
  • 図表
  • 目次
概要

フェムテックの世界市場規模は、2024年の438億6,000万米ドルから2033年には1,741億8,000万米ドルに成長し、2026年から2033年の予測期間中に16.56％の堅調な年間平均成長率（CAGR）を示すと予測されます。

フェムテック市場は、革新的な技術ソリューションを通じて女性特有の健康ニーズに対応するため、変革的な成長を遂げようとしています。個別化ヘルスケアを重視する傾向が強まる中、この分野では生殖医療から慢性疾患管理まで幅広いアプリケーションの急増が見られます。人工知能と機械学習がフェムテック製品に統合されることで、診断精度と患者エンゲージメントが向上し、女性の健康に対するより積極的なアプローチが促進されます。社会規範が進化し、女性の健康問題を取り巻く偏見が薄れるにつれて、このニッチ市場への投資と技術革新を促進し、テーラーメイドのソリューションに対する需要は拡大すると予想されます。

さらに、遠隔医療とモバイルヘルスアプリケーションの台頭は、女性がヘルスケアサービスにアクセスする方法に革命をもたらしました。遠隔診察の利便性と、ウェアラブルデバイスを通じて健康指標をモニターする能力は、女性の健康管理の状況を再形成しています。フェムテック企業がデータ分析を活用して実用的な洞察を提供し続けるにつれて、健康状態の改善の可能性はますます具体的になっています。この動向は、性別に特化した健康ソリューションの重要性を強調する調査の増加によってさらに裏付けられており、ベンチャーキャピタルと戦略的パートナーシップの両方を引き付け、この分野のさらなる進歩に拍車をかける可能性が高いです。

さらに、規制の枠組みは、フェムテック空間内のユニークな課題と機会に対応するために徐々に適応しつつあります。政府や医療機関が女性の健康への投資の重要性を認識するにつれ、技術革新と商業化にとってより有利な環境が予想されます。テクノロジー、ヘルスケア、社会的意識の融合は、フェムテック市場を有利な機会としてだけでなく、より広範なヘルスケア・エコシステムの重要な構成要素として位置づけています。将来を展望すると、女性の健康を再定義するフェムテックの可能性は計り知れず、ヘルスケア提供へのより包括的で効果的なアプローチを約束します。

目次

第1章 序文

第2章 エグゼクティブサマリー

  • 市場のハイライト
  • 世界市場スナップショット

第3章 フェムテック：産業分析

  • イントロダクション：市場力学
  • 市場促進要因
  • 市場抑制要因
  • 市場機会
  • 業界動向
  • ファイブフォース分析
  • 市場の魅力分析

第4章 バリューチェーン分析

  • バリューチェーン分析
  • 原材料分析
    • 原材料リスト
    • 原材料メーカーリスト
    • 主要原材料の価格動向
  • 潜在的バイヤーリスト
  • マーケティングチャネル
    • ダイレクトマーケティング
    • インダイレクトマーケティング
    • マーケティングチャネル発展動向

第5章 フェムテックの世界市場分析：タイプ別

  • タイプ別概要
  • タイプ別過去および予測データ分析
  • デバイス
  • ソフトウェア
  • サービス
  • 消費者向け製品

第6章 フェムテックの世界市場分析：用途別

  • 概要：用途別
  • 過去・予測データ分析：用途別
  • 妊娠と介護
  • リプロダクティブヘルスと避妊
  • 月経の健康
  • 一般健康
  • 骨盤と子宮の健康
  • 性の健康
  • 女性の健康
  • 更年期ケア
  • 長寿とメンタルヘルス

第7章 フェムテックの世界市場分析：最終用途別

  • 最終用途別概要
  • エンドユース別の実績データと予測データ分析
  • 消費者への直接販売
  • 病院
  • 手術センター
  • 不妊治療クリニック
  • 診断センター
  • その他

第8章 フェムテックの世界市場分析：地域別

  • 地域別展望
  • イントロダクション
  • 北米の売上分析
    • 概要、実績と予測
    • 北米：セグメント別
    • 北米：国別
    • 米国
    • カナダ
    • メキシコ
  • 欧州の売上分析
    • 概要、実績と予測
    • 欧州：セグメント別
    • 欧州：国別
    • 英国
    • フランス
    • ドイツ
    • イタリア
    • ロシア
    • その他欧州
  • アジア太平洋地域の売上分析
    • 概要、実績と予測
    • アジア太平洋地域：セグメント別
    • アジア太平洋地域：国別
    • 中国
    • インド
    • 日本
    • 韓国
    • オーストラリア
    • 東南アジア
    • その他アジア太平洋地域
  • ラテンアメリカの売上分析
    • 概要、実績と予測
    • ラテンアメリカ：セグメント別
    • ラテンアメリカ：国別
    • ブラジル
    • アルゼンチン
    • ペルー
    • チリ
    • その他ラテンアメリカ
  • 中東・アフリカの売上分析
    • 概要、実績と予測
    • 中東・アフリカ：セグメント別
    • 中東・アフリカ：国別
    • サウジアラビア
    • アラブ首長国連邦
    • イスラエル
    • 南アフリカ
    • その他中東とアフリカ

第9章 フェムテック企業の競合情勢

  • フェムテック市場の競合
  • 提携・協力・合意
  • 合併・買収
  • 新製品の発売
  • その他の開発

第10章 企業プロファイル

  • 上位企業の市場シェア分析
  • 市場集中度
  • Chiaro Technology Limited
  • HeraMED
  • Flo Health Inc.
  • Natural Cycles USA Corp
  • Glow Inc.
  • Allara Health
  • NUVO Inc.
  • Bloomlife
  • Syrona Health
  • Sirona Hygiene Private Limited
  • Samplytics Technologies Private Limited
  • ISono Health Inc.
  • Athena Feminine Technologies
図表

LIST OF TABLES

  • Market Snapshot
  • Drivers: Impact Analysis
  • Restraints: Impact Analysis
  • List of Raw Material
  • List of Raw Material Manufactures
  • Analysis By Type (USD MN)
  • Devices Market Sales By Geography (USD MN)
  • Software Market Sales By Geography (USD MN)
  • Services Market Sales By Geography (USD MN)
  • Consumer Products Market Sales By Geography (USD MN)
  • Analysis By Application (USD MN)
  • Pregnancy and Nursing Care Market Sales By Geography (USD MN)
  • Reproductive Health & Contraception Market Sales By Geography (USD MN)
  • Menstrual Health Market Sales By Geography (USD MN)
  • General Health Market Sales By Geography (USD MN)
  • Pelvic & Uterine Health Market Sales By Geography (USD MN)
  • Sexual Health Market Sales By Geography (USD MN)
  • Womens Wellness Market Sales By Geography (USD MN)
  • Menopause Care Market Sales By Geography (USD MN)
  • Longevity & Mental Health Market Sales By Geography (USD MN)
  • Analysis By End-use (USD MN)
  • Direct to Consumer Market Sales By Geography (USD MN)
  • Hospitals Market Sales By Geography (USD MN)
  • Surgical Centers Market Sales By Geography (USD MN)
  • Fertility Clinics Market Sales By Geography (USD MN)
  • Diagnostic Centers Market Sales By Geography (USD MN)
  • Others Market Sales By Geography (USD MN)
  • Global Femtech Market Sales By Geography (USD MN)
  • North America Market Analysis (USD MN)
  • United States Market Analysis (USD MN)
  • Canada Market Analysis (USD MN)
  • Mexico Market Analysis (USD MN)
  • Europe Market Analysis (USD MN)
  • Europe Market Estimate By Country (USD MN)
  • United Kingdom Market Analysis (USD MN)
  • France Market Analysis (USD MN)
  • Germany Market Analysis (USD MN)
  • Italy Market Analysis (USD MN)
  • Russia Market Analysis (USD MN)
  • Spain Market Analysis (USD MN)
  • Rest of Europe Market Analysis (USD MN)
  • Asia Pacific Market Analysis (USD MN)
  • China Market Analysis (USD MN)
  • Japan Market Analysis (USD MN)
  • India Market Analysis (USD MN)
  • South Korea Market Analysis (USD MN)
  • Australia Market Analysis (USD MN)
  • South East Asia Market Analysis (USD MN)
  • Rest of Asia Pacific Market Analysis (USD MN)
  • Latin America Market Analysis (USD MN)
  • Brazil Market Analysis (USD MN)
  • Argentina Market Analysis (USD MN)
  • Peru Market Analysis (USD MN)
  • Chile Market Analysis (USD MN)
  • Rest of Latin America Market Analysis (USD MN)
  • Middle East & Africa Market Analysis (USD MN)
  • Saudi Arabia Market Analysis (USD MN)
  • UAE Market Analysis (USD MN)
  • Israel Market Analysis (USD MN)
  • South Africa Market Analysis (USD MN)
  • Rest of Middle East and Africa Market Analysis (USD MN)
  • Partnership/Collaboration/Agreement
  • Mergers And Acquisition

LIST OF FIGURES

  • Research Scope of Femtech Report
  • Market Research Process
  • Market Research Methodology
  • Global Femtech Market Size, By Region (USD MN)
  • Porters Five Forces Analysis
  • Market Attractiveness Analysis By Type
  • Market Attractiveness Analysis By Application
  • Market Attractiveness Analysis By End-use
  • Market Attractiveness Analysis By Region
  • Value Chain Analysis
  • Global Market Analysis By Type (USD MN)
  • Devices Market Sales By Geography (USD MN)
  • Software Market Sales By Geography (USD MN)
  • Services Market Sales By Geography (USD MN)
  • Consumer Products Market Sales By Geography (USD MN)
  • Global Market Analysis By Application (USD MN)
  • Pregnancy and Nursing Care Market Sales By Geography (USD MN)
  • Reproductive Health & Contraception Market Sales By Geography (USD MN)
  • Menstrual Health Market Sales By Geography (USD MN)
  • General Health Market Sales By Geography (USD MN)
  • Pelvic & Uterine Health Market Sales By Geography (USD MN)
  • Sexual Health Market Sales By Geography (USD MN)
  • Womens Wellness Market Sales By Geography (USD MN)
  • Menopause Care Market Sales By Geography (USD MN)
  • Longevity & Mental Health Market Sales By Geography (USD MN)
  • Global Market Analysis By End-use (USD MN)
  • Direct to Consumer Market Sales By Geography (USD MN)
  • Hospitals Market Sales By Geography (USD MN)
  • Surgical Centers Market Sales By Geography (USD MN)
  • Fertility Clinics Market Sales By Geography (USD MN)
  • Diagnostic Centers Market Sales By Geography (USD MN)
  • Others Market Sales By Geography (USD MN)
  • Global Market Sales (USD MN)
  • North America Market Sales (USD MN)
  • Europe Market Sales (USD MN)
  • Asia Pacific Market Sales (USD MN)
  • Latin America Market Sales (USD MN)
  • Middle East & Africa Market Sales (USD MN)
  • Recent Development in Industry
  • Top Company Market Share Analysis

Kindly note that the above listed are the basic tables and figures of the report and are not limited to the TOC.

目次
Product Code: VMR112113223

Global Femtech Market size is anticipated to grow from USD 43.86 Billion in 2024 to USD 174.18 Billion by 2033, showcasing a robust Compound Annual Growth Rate (CAGR) of 16.56% during the forecast period of 2026 to 2033.

The Femtech market is poised for transformative growth as it addresses the unique health needs of women through innovative technology solutions. With an increasing emphasis on personalized healthcare, the sector is witnessing a surge in applications ranging from reproductive health to chronic disease management. The integration of artificial intelligence and machine learning into Femtech products is enhancing diagnostic accuracy and patient engagement, thereby fostering a more proactive approach to women's health. As societal norms evolve and the stigma surrounding women's health issues diminishes, the demand for tailored solutions is expected to escalate, driving investment and innovation in this niche market.

Moreover, the rise of telehealth and mobile health applications has revolutionized how women access healthcare services. The convenience of remote consultations and the ability to monitor health metrics through wearable devices are reshaping the landscape of women's health management. As Femtech companies continue to leverage data analytics to provide actionable insights, the potential for improved health outcomes becomes increasingly tangible. This trend is further supported by a growing body of research highlighting the importance of gender-specific health solutions, which is likely to attract both venture capital and strategic partnerships, fueling further advancements in the sector.

In addition, regulatory frameworks are gradually adapting to accommodate the unique challenges and opportunities within the Femtech space. As governments and health organizations recognize the importance of investing in women's health, we can anticipate a more favorable environment for innovation and commercialization. The convergence of technology, healthcare, and social awareness positions the Femtech market not only as a lucrative opportunity but also as a vital component of the broader healthcare ecosystem. As we look to the future, the potential for Femtech to redefine women's health is immense, promising a more inclusive and effective approach to healthcare delivery.

Our reports are meticulously crafted to provide clients with comprehensive and actionable insights into various industries and markets. Each report encompasses several critical components to ensure a thorough understanding of the market landscape:

Market Overview: A detailed introduction to the market, including definitions, classifications, and an overview of the industry's current state.

Market Dynamics: In-depth analysis of key drivers, restraints, opportunities, and challenges influencing market growth. This section examines factors such as technological advancements, regulatory changes, and emerging trends.

Segmentation Analysis: Breakdown of the market into distinct segments based on criteria like product type, application, end-user, and geography. This analysis highlights the performance and potential of each segment.

Competitive Landscape: Comprehensive assessment of major market players, including their market share, product portfolio, strategic initiatives, and financial performance. This section provides insights into the competitive dynamics and key strategies adopted by leading companies.

Market Forecast: Projections of market size and growth trends over a specified period, based on historical data and current market conditions. This includes quantitative analyses and graphical representations to illustrate future market trajectories.

Regional Analysis: Evaluation of market performance across different geographical regions, identifying key markets and regional trends. This helps in understanding regional market dynamics and opportunities.

Emerging Trends and Opportunities: Identification of current and emerging market trends, technological innovations, and potential areas for investment. This section offers insights into future market developments and growth prospects.

SEGMENTATION COVERED IN THE REPORT

By Type

  • Devices
  • Software
  • Services
  • Consumer Products

By Application

  • Pregnancy and Nursing Care
  • Reproductive Health & Contraception
  • Menstrual Health
  • General Health
  • Pelvic & Uterine Health
  • Sexual Health
  • Womens Wellness
  • Menopause Care
  • Longevity & Mental Health

By End-use

  • Direct to Consumer
  • Hospitals
  • Surgical Centers
  • Fertility Clinics
  • Diagnostic Centers
  • Others
  • COMPANIES PROFILED
  • Chiaro Technology Limited
  • HeraMED
  • Flo Health Inc.
  • Natural Cycles USA Corp
  • Glow Inc.
  • Allara Health
  • NUVO Inc.
  • Bloomlife
  • Syrona Health
  • Sirona Hygiene Private Limited
  • Samplytics Technologies Private Limited
  • iSono Health Inc.
  • Athena Feminine Technologies
  • The above list can be customized.

TABLE OF CONTENTS

1. PREFACE

  • 1.1. Report Description
    • 1.1.1 Objective
    • 1.1.2 Target Audience
    • 1.1.3 Unique Selling Proposition (USP) & offerings
  • 1.2. Research Scope
  • 1.3. Research Methodology
    • 1.3.1 Market Research Process
    • 1.3.2 Market Research Methodology

2. EXECUTIVE SUMMARY

  • 2.1. Highlights of Market
  • 2.2. Global Market Snapshot

3. FEMTECH INDUSTRY ANALYSIS

  • 3.1. Introduction - Market Dynamics
  • 3.2. Market Drivers
  • 3.3. Market Restraints
  • 3.4. Opportunities
  • 3.5. Industry Trends
  • 3.6. Poerter's Five Force Analysis
  • 3.7. Market Attractiveness Analysis
    • 3.7.1 Market Attractiveness Analysis By Type
    • 3.7.2 Market Attractiveness Analysis By Application
    • 3.7.3 Market Attractiveness Analysis By End-use
    • 3.7.4 Market Attractiveness Analysis By Region

4. VALUE CHAIN ANALYSIS

  • 4.1. Value Chain Analysis
  • 4.2. Raw Material Analysis
    • 4.2.1 List of Raw Materials
    • 4.2.2 Raw Material Manufactures List
    • 4.2.3 Price Trend of Key Raw Materials
  • 4.3. List of Potential Buyers
  • 4.4. Marketing Channel
    • 4.4.1 Direct Marketing
    • 4.4.2 Indirect Marketing
    • 4.4.3 Marketing Channel Development Trend

5. GLOBAL FEMTECH MARKET ANALYSIS BY TYPE

  • 5.1. Overview By Type
  • 5.2. Historical and Forecast Data Analysis By Type
  • 5.3. Devices Historic and Forecast Sales By Regions
  • 5.4. Software Historic and Forecast Sales By Regions
  • 5.5. Services Historic and Forecast Sales By Regions
  • 5.6. Consumer Products Historic and Forecast Sales By Regions

6. GLOBAL FEMTECH MARKET ANALYSIS BY APPLICATION

  • 6.1. Overview By Application
  • 6.2. Historical and Forecast Data Analysis By Application
  • 6.3. Pregnancy and Nursing Care Historic and Forecast Sales By Regions
  • 6.4. Reproductive Health & Contraception Historic and Forecast Sales By Regions
  • 6.5. Menstrual Health Historic and Forecast Sales By Regions
  • 6.6. General Health Historic and Forecast Sales By Regions
  • 6.7. Pelvic & Uterine Health Historic and Forecast Sales By Regions
  • 6.8. Sexual Health Historic and Forecast Sales By Regions
  • 6.9. Womens Wellness Historic and Forecast Sales By Regions
  • 6.10. Menopause Care Historic and Forecast Sales By Regions
  • 6.11. Longevity & Mental Health Historic and Forecast Sales By Regions

7. GLOBAL FEMTECH MARKET ANALYSIS BY END-USE

  • 7.1. Overview By End-use
  • 7.2. Historical and Forecast Data Analysis By End-use
  • 7.3. Direct to Consumer Historic and Forecast Sales By Regions
  • 7.4. Hospitals Historic and Forecast Sales By Regions
  • 7.5. Surgical Centers Historic and Forecast Sales By Regions
  • 7.6. Fertility Clinics Historic and Forecast Sales By Regions
  • 7.7. Diagnostic Centers Historic and Forecast Sales By Regions
  • 7.8. Others Historic and Forecast Sales By Regions

8. GLOBAL FEMTECH MARKET ANALYSIS BY GEOGRAPHY

  • 8.1. Regional Outlook
  • 8.2. Introduction
  • 8.3. North America Sales Analysis
    • 8.3.1 Overview, Historic and Forecast Data Sales Analysis
    • 8.3.2 North America By Segment Sales Analysis
    • 8.3.3 North America By Country Sales Analysis
    • 8.3.4 United States Sales Analysis
    • 8.3.5 Canada Sales Analysis
    • 8.3.6 Mexico Sales Analysis
  • 8.4. Europe Sales Analysis
    • 8.4.1 Overview, Historic and Forecast Data Sales Analysis
    • 8.4.2 Europe By Segment Sales Analysis
    • 8.4.3 Europe By Country Sales Analysis
    • 8.4.4 United Kingdom Sales Analysis
    • 8.4.5 France Sales Analysis
    • 8.4.6 Germany Sales Analysis
    • 8.4.7 Italy Sales Analysis
    • 8.4.8 Russia Sales Analysis
    • 8.4.9 Rest Of Europe Sales Analysis
  • 8.5. Asia Pacific Sales Analysis
    • 8.5.1 Overview, Historic and Forecast Data Sales Analysis
    • 8.5.2 Asia Pacific By Segment Sales Analysis
    • 8.5.3 Asia Pacific By Country Sales Analysis
    • 8.5.4 China Sales Analysis
    • 8.5.5 India Sales Analysis
    • 8.5.6 Japan Sales Analysis
    • 8.5.7 South Korea Sales Analysis
    • 8.5.8 Australia Sales Analysis
    • 8.5.9 South East Asia Sales Analysis
    • 8.5.10 Rest Of Asia Pacific Sales Analysis
  • 8.6. Latin America Sales Analysis
    • 8.6.1 Overview, Historic and Forecast Data Sales Analysis
    • 8.6.2 Latin America By Segment Sales Analysis
    • 8.6.3 Latin America By Country Sales Analysis
    • 8.6.4 Brazil Sales Analysis
    • 8.6.5 Argentina Sales Analysis
    • 8.6.6 Peru Sales Analysis
    • 8.6.7 Chile Sales Analysis
    • 8.6.8 Rest of Latin America Sales Analysis
  • 8.7. Middle East & Africa Sales Analysis
    • 8.7.1 Overview, Historic and Forecast Data Sales Analysis
    • 8.7.2 Middle East & Africa By Segment Sales Analysis
    • 8.7.3 Middle East & Africa By Country Sales Analysis
    • 8.7.4 Saudi Arabia Sales Analysis
    • 8.7.5 UAE Sales Analysis
    • 8.7.6 Israel Sales Analysis
    • 8.7.7 South Africa Sales Analysis
    • 8.7.8 Rest Of Middle East And Africa Sales Analysis

9. COMPETITIVE LANDSCAPE OF THE FEMTECH COMPANIES

  • 9.1. Femtech Market Competition
  • 9.2. Partnership/Collaboration/Agreement
  • 9.3. Merger And Acquisitions
  • 9.4. New Product Launch
  • 9.5. Other Developments

10. COMPANY PROFILES OF FEMTECH INDUSTRY

  • 10.1. Top Companies Market Share Analysis
  • 10.2. Market Concentration Rate
  • 10.3. Chiaro Technology Limited
    • 10.3.1 Company Overview
    • 10.3.2 Company Revenue
    • 10.3.3 Products
    • 10.3.4 Recent Developments
  • 10.4. HeraMED
    • 10.4.1 Company Overview
    • 10.4.2 Company Revenue
    • 10.4.3 Products
    • 10.4.4 Recent Developments
  • 10.5. Flo Health Inc.
    • 10.5.1 Company Overview
    • 10.5.2 Company Revenue
    • 10.5.3 Products
    • 10.5.4 Recent Developments
  • 10.6. Natural Cycles USA Corp
    • 10.6.1 Company Overview
    • 10.6.2 Company Revenue
    • 10.6.3 Products
    • 10.6.4 Recent Developments
  • 10.7. Glow Inc.
    • 10.7.1 Company Overview
    • 10.7.2 Company Revenue
    • 10.7.3 Products
    • 10.7.4 Recent Developments
  • 10.8. Allara Health
    • 10.8.1 Company Overview
    • 10.8.2 Company Revenue
    • 10.8.3 Products
    • 10.8.4 Recent Developments
  • 10.9. NUVO Inc.
    • 10.9.1 Company Overview
    • 10.9.2 Company Revenue
    • 10.9.3 Products
    • 10.9.4 Recent Developments
  • 10.10. Bloomlife
    • 10.10.1 Company Overview
    • 10.10.2 Company Revenue
    • 10.10.3 Products
    • 10.10.4 Recent Developments
  • 10.11. Syrona Health
    • 10.11.1 Company Overview
    • 10.11.2 Company Revenue
    • 10.11.3 Products
    • 10.11.4 Recent Developments
  • 10.12. Sirona Hygiene Private Limited
    • 10.12.1 Company Overview
    • 10.12.2 Company Revenue
    • 10.12.3 Products
    • 10.12.4 Recent Developments
  • 10.13. Samplytics Technologies Private Limited
    • 10.13.1 Company Overview
    • 10.13.2 Company Revenue
    • 10.13.3 Products
    • 10.13.4 Recent Developments
  • 10.14. ISono Health Inc.
    • 10.14.1 Company Overview
    • 10.14.2 Company Revenue
    • 10.14.3 Products
    • 10.14.4 Recent Developments
  • 10.15. Athena Feminine Technologies
    • 10.15.1 Company Overview
    • 10.15.2 Company Revenue
    • 10.15.3 Products
    • 10.15.4 Recent Developments

Note - In company profiling, financial details and recent developments are subject to availability or might not be covered in the case of private companies